NUS Nu Skin Enterprises Inc

Price (delayed)

$10.9

Market cap

$539.53M

P/E Ratio

5.34

Dividend/share

$0.24

EPS

$2.04

Enterprise value

$586.1M

?
Relative Growth: Rel. Growth: 34
Relative Strength: Rel. Strength: 90
Relative Valuation: Rel. Valuation: 99
Relative Profitability: Rel. Profitability: 80

Founded more than 35 years ago, Nu Skin Enterprises, Inc. empowers innovative companies to change the world with sustainable solutions, opportunities, technologies and life-improving values. The company currently focuses its ...

Highlights
The net income has surged by 168% year-on-year
The company's EPS has surged by 168% YoY
The debt has declined by 41% year-on-year but it has increased by 3.3% since the previous quarter
NUS's revenue is down by 12% YoY and by 3.2% from the previous quarter
The gross profit has contracted by 12% YoY and by 3.7% from the previous quarter

Key stats

What are the main financial stats of NUS
Market
Shares outstanding
49.5M
Market cap
$539.53M
Enterprise value
$586.1M
Valuations
Price to earnings (P/E)
5.34
Price to book (P/B)
0.68
Price to sales (P/S)
0.33
PEG
0.03
EV/EBIT
4.32
EV/EBITDA
2.64
EV/Sales
0.36
Earnings
Revenue
$1.63B
Gross profit
$1.09B
Operating income
-$13.97M
Net income
$100.83M
EBIT
$135.68M
EBITDA
$221.6M
Free cash flow
$58.62M
Per share
EPS
$2.04
EPS diluted
$2.02
Free cash flow per share
$1.19
Book value per share
$15.94
Revenue per share
$32.89
TBVPS
$26.58
Balance sheet
Total assets
$1.44B
Total liabilities
$655.94M
Debt
$310.74M
Equity
$787.75M
Working capital
$287.65M
Liquidity
Debt to equity
0.39
Current ratio
2.01
Quick ratio
1.15
Net debt/EBITDA
0.21
Margins
EBITDA margin
13.6%
Gross margin
67.2%
Net margin
6.2%
Operating margin
-0.9%
Efficiency
Return on assets
6.9%
Return on equity
13.9%
Return on invested capital
11.3%
Return on capital employed
11.7%
Return on sales
8.3%
Dividend
Dividend yield
2.2%
DPS
$0.24
Payout ratio
11.8%

NUS stock price

How has the Nu Skin Enterprises stock price performed over time
Intraday
-1.71%
1 week
2.64%
1 month
-4.8%
1 year
68.21%
YTD
58.2%
QTD
-10.58%

Financial performance

How have Nu Skin Enterprises's revenue and profit performed over time
Revenue
$1.63B
Gross profit
$1.09B
Operating income
-$13.97M
Net income
$100.83M
Gross margin
67.2%
Net margin
6.2%
The net margin has surged by 177% year-on-year
The net income has surged by 168% year-on-year
The company's operating income has surged by 92% QoQ and by 89% YoY
Nu Skin Enterprises's operating margin has surged by 91% QoQ and by 87% YoY

Price vs fundamentals

How does NUS's price correlate with its fundamentals

Growth

What is Nu Skin Enterprises's growth rate over time

Valuation

What is Nu Skin Enterprises stock price valuation
P/E
5.34
P/B
0.68
P/S
0.33
EV/EBIT
4.32
EV/EBITDA
2.64
EV/Sales
0.36
The company's EPS has surged by 168% YoY
The P/B is 61% below the 5-year quarterly average of 1.8 but 40% above the last 4 quarters average of 0.5
NUS's equity is up by 15% year-on-year and by 4.5% since the previous quarter
The price to sales (P/S) is 70% higher than the last 4 quarters average of 0.2 but 51% lower than the 5-year quarterly average of 0.7
NUS's revenue is down by 12% YoY and by 3.2% from the previous quarter

Efficiency

How efficient is Nu Skin Enterprises business performance
The ROA has soared by 180% YoY
The company's return on equity has surged by 174% YoY

Dividends

What is NUS's dividend history
DPS
$0.24
Dividend yield
2.2%
Payout ratio
11.8%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Nu Skin Enterprises financials performed over time
The total assets is 120% more than the total liabilities
Nu Skin Enterprises's total liabilities has decreased by 27% YoY but it has increased by 2.9% QoQ
The quick ratio is up by 16% year-on-year and by 11% since the previous quarter
The debt is 61% smaller than the equity
The debt to equity has declined by 49% year-on-year and by 2.5% since the previous quarter
The debt has declined by 41% year-on-year but it has increased by 3.3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.